๐Ÿš€ Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. ๐Ÿ”ฅ
Login

News on Medial

Related News

Cellarim Labs raises seed round led by 3i Partners and Venture Catalysts

EntrackrEntrackr ยท 20h ago
Cellarim Labs raises seed round led by 3i Partners and Venture Catalysts
Medial

Cellarim Labs, a biotechnology startup working on cell-free biomanufacturing for beauty and personal care ingredients, has raised Rs 6 crore in a seed funding round co-led by 3i Partners and Venture Catalysts. The round also saw participation from Momentum Capital, Jashan Bhumkar, Gayathri Kuppendra Reddy, and other investors. The proceeds will be used to set up a pilot-scale biomanufacturing facility, accelerate commercial production of NeuHyalโ„ข, and expand its B2B ingredient supply to beauty and cosmetic brands, Cellarim Labs said in a press release. Co-founded in 2023 by Hitesh Rafalia and Nisa Mehreen, Cellarim Labs focuses on developing alternative production methods for cosmetic ingredients. The startup aims to address issues in the beauty ingredients segment such as dependence on imported bioactives, supply volatility, variability in purity, and higher costs for brands. The company has developed a cell-free, enzyme-based manufacturing platform that replaces conventional fermentation and chemical synthesis processes. The platform combines enzyme engineering and bioprocessing to convert renewable bio-waste into cosmetic ingredients with consistent specifications. Cellarim Labs is also building an AI-driven biofoundry that enables partner brands to submit target molecules for design, testing, and production, with the aim of reducing development timelines for new bioactive ingredients. According to the company, it has launched NeuHyalโ„ข, a Hyaluronic Acid portfolio ranging from 10 kDa to 5000 kDa, developed within one year. The product line is positioned for use across skincare, cosmetic, and related applications, offering an alternative to conventional Hyaluronic Acid sources. Cellarim Labs is initially targeting the global Hyaluronic Acid market, which is estimated at $9 billion and serves applications across skincare, dermal fillers, and medical grade use cases.

Bio-tech startup Cellivate Technologies raises $1 Mn in seed round

EntrackrEntrackr ยท 1y ago
Bio-tech startup Cellivate Technologies raises $1 Mn in seed round
Medial

Bio-tech startup Cellivate Technologies has raised $1 million in a seed round led by Antler along with participation from Venture Catalysts, Hatcher+, and We Founder Circle. The funds will be used to accelerate its R&D efforts, scale up production of its innovative products, and expand its market reach, Cellivate said in a press release. Launched by Viknish Krishnan Kutty, Cellivate is developing innovative solutions to address critical challenges in cell culture and biomanufacturing. The companyโ€™s flagship products include advanced microcarriers for scaling up cell growth and a novel cell-based serum designed to replace fetal bovine serum. According to market research, the cell culture market, especially concerning microcarriers and serum, is expected to reach $33 billion by 2030. Cellivate says that its advanced microcarriers and cell-based serum alternatives have the potential to reduce costs, increase efficiency, and address ethical concerns in cell culture processes. Advancements in cell culture and biomanufacturing-related technologies will reduce societyโ€™s dependence on animal slaughter since several products/ingredients conventionally derived from animals can be procured from cells.

You Care Lifestyle raises $1 Mn in pre-seed round

EntrackrEntrackr ยท 10m ago
You Care Lifestyle raises $1 Mn in pre-seed round
Medial

You Care Lifestyle raises $1 Mn in pre-seed round Independent verification platform You Care Lifestyle (YCL) has raised $1 million in a pre-seed funding round co-led by Luke Coutinho and Narendra Firodiya. The proceeds will be used to strengthen the processes for verification and authentication of products, support and invest in emerging clean brands, helping them scale and gain consumer trust, YCL said in a press release. Launched this year, You Care Lifestyle is an independent verification entity in the health and wellness space. The company verifies the safety, purity, and quality of products and services across various categories, including groceries, food, nutraceuticals, beauty and personal care items, pathology labs, and other lifestyle-related offerings. The Mumbai-based startup aims to create a trustworthy third-party verification platform, addresses critical issues like mislabelling and misinformation, and drives a behaviour shift towards informed consumer choice. YCL aims to empower brands to prioritise health-conscious products and to uphold the highest quality standards, and consumers to prioritise health-conscious decisions and inspire them to make choices of authentic products. YCL intends to expand the companyโ€™s offerings and plans to onboard brands. The company will look to test and verify approx 90-100 brands across food and cosmetic sectors by the end of 2025. The startup claims that it has signed with 37 products, 24 of which have successfully passed third-party lab tests, and 18 products are now available on the website. These products will feature the distinctive 'Pink Tiger Stamp,' an independent verification mark that signifies both approval and the quality assurance of the ingredients after rigorous testing. YCL aspires to bridge the gap between authenticity and consumer trust by creating a rigorous and reliable third-party verification system. The platform is committed to identifying and investing in businesses that share a vision of transparency, integrity, and consumer well-being.

Genexis Biotech raises Rs 4 Cr in seed round led by GVFL

EntrackrEntrackr ยท 4m ago
Genexis Biotech raises Rs 4 Cr in seed round led by GVFL
Medial

Genexis Biotech raises Rs 4 Cr in seed round led by GVFL Vadodara-based bio-manufacturing startup Genexis Biotech has raised Rs 4 crore in a seed funding round led by GVFL, with participation from Benzai10. The proceeds will be used to scale bioreactor capacity, build downstream processing infrastructure, launch new recombinant proteins and enzymes, and strengthen compliance, sales, and distribution functions. Genexis Biotech develops animal-origin-free recombinant proteins using precision fermentation, catering to sectors like biopharma, food-tech, and cell culture. The startup operates a certified Class 10,000 facility and is setting up a GMP-compliant unit. It has introduced recombinant peptidases such as amino peptidase and enterokinase, and plans to launch recombinant transferrin and albumin. In the past year, Genexis established partnerships with pharmaceutical companies and biotech firms, signed an MoU with the Gujarat government, and received client orders for alternative protein formulations. It showcased its portfolio at Global Bio-India 2024 and aims to enter the regulated biotech export market, develop encapsulated formulations for the cosmetics industry, and collaborate with CDMOs, academic labs, and biopharma firms. Genexis Biotech focuses on scalable, ethical biomolecule production. GVFL has backed the company as part of its investment thesis across deeptech and biotech innovation.

Download the medial app to read full posts, comements and news.